Role of farnesoid X receptor in cholestasis

被引:40
|
作者
Yuan, Zhi Qing [1 ]
Li, Ke Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China
关键词
bile acid; cholestasis; enterohepatic circulation; farnesoid X receptor; hepatobiliary transport; ORGANIC SOLUTE TRANSPORTER; SALT EXPORT PUMP; BILE-ACID HOMEOSTASIS; CANALICULAR ABC TRANSPORTERS; ANIT-INDUCED HEPATOTOXITY; FXR-MEDIATED REGULATION; ALPHA-OST-BETA; NF-KAPPA-B; NUCLEAR RECEPTOR; DOWN-REGULATION;
D O I
10.1111/1751-2980.12378
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The nuclear receptor farnesoid X receptor (FXR) plays an important role in physiological bile acid synthesis, secretion and transport. Defects of FXR regulation in these processes can cause cholestasis and subsequent pathological changes. FXR regulates the synthesis and uptake of bile acid via enzymes. It also increases bile acid solubility and elimination by promoting conjugation reactions and exports pump expression in cholestasis. The changes in bile acid transporters are involved in cholestasis, which can result from the mutations of transporter genes or acquired dysfunction of transport systems, such as inflammation-induced intrahepatic cholestasis. The modulation function of FXR in extrahepatic cholestasis is not identical to that in intrahepatic cholestasis, but the discrepancy may be reduced over time. In extrahepatic cholestasis, increasing biliary pressure can induce bile duct proliferation and bile infarcts, but the absence of FXR may ameliorate them. This review provides an update on the function of FXR in the regulation of bile acid metabolism, its role in the pathophysiological process of cholestasis and the therapeutic use of FXR agonists.
引用
收藏
页码:501 / 509
页数:9
相关论文
共 50 条
  • [11] Alisma orientale extract exerts the reversing cholestasis effect by activation of farnesoid X receptor
    Huo, Xiao-Kui
    Liu, Jing
    Yu, Zhen-Long
    Wang, Yi-Fei
    Wang, Chao
    Tian, Xiang-Ge
    Ning, Jing
    Feng, Lei
    Sun, Cheng-Peng
    Zhang, Bao-Jing
    Ma, Xiao-Chi
    PHYTOMEDICINE, 2018, 42 : 34 - 42
  • [12] Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
    Petrescu, Anca D.
    DeMorrow, Sharon
    CELLS, 2021, 10 (08)
  • [13] Glucocorticoids Promote Hepatic Cholestasis in Mice by Inhibiting the Transcriptional Activity of the Farnesoid X Receptor
    Lu, Yan
    Zhang, Zhijian
    Xiong, Xuelian
    Wang, Xiaolin
    Li, Jin
    Shi, Guojun
    Yang, Jian
    Zhang, Xianfeng
    Zhang, Huijie
    Hong, Jie
    Xia, Xuefeng
    Ning, Guang
    Li, Xiaoying
    GASTROENTEROLOGY, 2012, 143 (06) : 1630 - +
  • [14] Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity
    Chen, F
    Ananthanarayanan, M
    Emre, S
    Neimark, E
    Bull, LN
    Knisely, AS
    Strautnieks, SS
    Thompson, RJ
    Magid, MS
    Gordon, R
    Balasubramanian, N
    Suchy, FJ
    Shneider, BL
    GASTROENTEROLOGY, 2004, 126 (03) : 756 - 764
  • [15] Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro
    Gao, Xiaoguang
    Fu, Ting
    Wang, Changyuan
    Ning, Chenqing
    Liu, Kexin
    Liu, Zhihao
    Sun, Huijun
    Ma, Xiaodong
    Huo, Xiaokui
    Yang, Xiaobo
    Zou, Ming
    Meng, Qiang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 348 : 105 - 116
  • [16] Hepatoprotection by S-adenosylmethionine and the associated mechanism with farnesoid X receptor in intrahepatic cholestasis rats
    Mao, Hua
    Ouyang, Junhui
    Jin, Dandan
    Qiu, Wendan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 197 - 197
  • [17] -Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis
    Thompson, Michael D.
    Moghe, Akshata
    Cornuet, Pamela
    Marino, Rebecca
    Tian, Jianmin
    Wang, Pengcheng
    Ma, Xiaochao
    Abrams, Marc
    Locker, Joseph
    Monga, Satdarshan P.
    Nejak-Bowen, Kari
    HEPATOLOGY, 2018, 67 (03) : 955 - 971
  • [18] Potential regulatory role of the farnesoid X receptor in the metabolic syndrome
    Duran-Sandoval, D
    Cariou, B
    Fruchart, JC
    Staels, B
    BIOCHIMIE, 2005, 87 (01) : 93 - 98
  • [19] Role of farnesoid X receptor in regulating hepatic lipid homeostasis
    Kong, Bo
    Esterly, Noriko
    Rengasamy, Manimaran
    Guo, Grace
    HEPATOLOGY, 2007, 46 (04) : 784A - 784A
  • [20] Pregnane X receptor is a target of farnesoid X receptor
    Jung, Diana
    Mangelsdorf, David J.
    Meyer, Urs A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) : 19081 - 19091